FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061569374> ?p ?o ?g. }

• W2061569374 endingPage "10050" @default.
• W2061569374 startingPage "10046" @default.
• W2061569374 abstract "Canalicular secretion of bile salts is a vital function of the vertebrate liver, yet the molecular identity of the involved ATP-dependent carrier protein has not been elucidated. We cloned the full-length cDNA of the sister of P-glycoprotein (spgp; Mr ∼160,000) of rat liver and demonstrated that it functions as an ATP-dependent bile salt transporter in cRNA injectedXenopus laevis oocytes and in vesicles isolated from transfected Sf9 cells. The latter demonstrated a 5-fold stimulation of ATP-dependent taurocholate transport as compared with controls. This spgp-mediated taurocholate transport was stimulated solely by ATP, was inhibited by vanadate, and exhibited saturability with increasing concentrations of taurocholate (Km ≃ 5 μm). Furthermore, spgp-mediated transport rates of various bile salts followed the same order of magnitude as ATP-dependent transport in canalicular rat liver plasma membrane vesicles, i.e.taurochenodeoxycholate > tauroursodeoxycholate = taurocholate > glycocholate = cholate. Tissue distribution assessed by Northern blotting revealed predominant, if not exclusive, expression of spgp in the liver, where it was further localized to the canalicular microvilli and to subcanalicular vesicles of the hepatocytes by in situ immunofluorescence and immunogold labeling studies. These results indicate that the sister of P-glycoprotein is the major canalicular bile salt export pump of mammalian liver. Canalicular secretion of bile salts is a vital function of the vertebrate liver, yet the molecular identity of the involved ATP-dependent carrier protein has not been elucidated. We cloned the full-length cDNA of the sister of P-glycoprotein (spgp; Mr ∼160,000) of rat liver and demonstrated that it functions as an ATP-dependent bile salt transporter in cRNA injectedXenopus laevis oocytes and in vesicles isolated from transfected Sf9 cells. The latter demonstrated a 5-fold stimulation of ATP-dependent taurocholate transport as compared with controls. This spgp-mediated taurocholate transport was stimulated solely by ATP, was inhibited by vanadate, and exhibited saturability with increasing concentrations of taurocholate (Km ≃ 5 μm). Furthermore, spgp-mediated transport rates of various bile salts followed the same order of magnitude as ATP-dependent transport in canalicular rat liver plasma membrane vesicles, i.e.taurochenodeoxycholate > tauroursodeoxycholate = taurocholate > glycocholate = cholate. Tissue distribution assessed by Northern blotting revealed predominant, if not exclusive, expression of spgp in the liver, where it was further localized to the canalicular microvilli and to subcanalicular vesicles of the hepatocytes by in situ immunofluorescence and immunogold labeling studies. These results indicate that the sister of P-glycoprotein is the major canalicular bile salt export pump of mammalian liver. Bile formation is an important function of vertebrate liver (1Oude Elferink R.P.J. Meijer D.K.F. Kuipers F. Jansen P.L.M. Groen A.K. Grotthuis G.M.M. Biochim. Biophys. Acta. 1995; 1241: 215-268Crossref PubMed Scopus (384) Google Scholar). It is mediated by hepatocytes that generate bile flow within bile canaliculi by continuous vectorial secretion of bile salts and other solutes across their canalicular (apical) membrane (2Nathanson M.H. Boyer J.L. Hepatology. 1991; 14: 551-566Crossref PubMed Scopus (385) Google Scholar). Studies in isolated membrane vesicles of rat and human livers have shown that canalicular bile salt transport is an ATP-dependent process (3Adachi Y. Kobayashi H. Kurumi Y. Shouji M. Kitano M. Yamamoto T. Hepatology. 1991; 14: 655-659PubMed Google Scholar, 4Müller M. Ishikawa T. Berger U. Klünemann C. Lucka L. Schreyer A. Kannicht C. Reutter W. Kurz G. Keppler G. J. Biol. Chem. 1991; 266: 18920-18926Abstract Full Text PDF PubMed Google Scholar, 5Nishida T. Gatmaitan Z. Che M. Arias I.M. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 6590-6594Crossref PubMed Scopus (195) Google Scholar, 6Stieger B. O'Neill B. Meier P.J. Biochem. J. 1992; 284: 67-74Crossref PubMed Scopus (131) Google Scholar, 7Wolters H. Kuipers F. Slooff M.J. Vonk R.J. J. Clin. Invest. 1992; 90: 2321-2326Crossref PubMed Scopus (36) Google Scholar). However, the molecular identity of the primary active canalicular bile salt transporter or bile salt export pump (BSEP) 1The abbreviations use are: BSEP, bile salt export pump of mammalian liver; ABC, ATP binding cassette; BAT1, bile acid transporter of S. cerevisiae; mdr1a/1b, rodent isoforms of the multidrug resistance P-glycoprotein; mdr2, phospholipid-transporting mdr isoform of rodent liver; MRP1, human multidrug resistance protein 1; MRP2/mrp2, human/rat canalicular multidrug resistance protein; spgp, sister of P-glycoprotein; BSEP/spgp, identity of spgp and BSEP; PFIC, progressive familial intrahepatic cholestasis; bp base pair(s); kb, kilobase pair(s)., 2BSEP rather than cBAT (9Suchy F.J. Sippel C.J. Ananthanarayanan M. FASEB J. 1997; 11: 199-205Crossref PubMed Scopus (52) Google Scholar) or cBST (8Meier P.J. Am. J. Physiol. 1995; 269: G801-G812PubMed Google Scholar) is chosen as abbreviation, since BAT has already been reserved for “basic amino acid transporter” (47Bertran J. Magagnin S. Werner A. Markovich D. Biber J. Testar X. Zorzano A. Kuhn L.C. Palacin M. Murer H. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 5601-5605Crossref PubMed Scopus (198) Google Scholar) and BST for the sphingosine-phosphate lyase gene (48Saba J.D. Nara F. Bielawska A. Garrett S. Hannun Y.A. J. Biol. Chem. 1997; 272: 26087-26890Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar). Furthermore, the term “export pump” points to ATP as the primary driving force of the canalicular bile salt transporter.has not yet been elucidated (8Meier P.J. Am. J. Physiol. 1995; 269: G801-G812PubMed Google Scholar, 9Suchy F.J. Sippel C.J. Ananthanarayanan M. FASEB J. 1997; 11: 199-205Crossref PubMed Scopus (52) Google Scholar). Although the canalicular ecto-ATPase has been proposed as a possible candidate (9Suchy F.J. Sippel C.J. Ananthanarayanan M. FASEB J. 1997; 11: 199-205Crossref PubMed Scopus (52) Google Scholar, 10Sippel C.J. McCollum M.J. Perlmutter D.H. J. Biol. Chem. 1994; 269: 2820-2826Abstract Full Text PDF PubMed Google Scholar), other investigations have provided evidence that BSEP of mammalian liver is an ABC (ATP binding cassette)-type of membrane transporter (11Brown R. Lomri N. DeVoss J. Xie M.H. Hua T. Lidofsky S.D. Scharschmidt B.F. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 5421-5425Crossref PubMed Scopus (28) Google Scholar, 12Luther T.T. Hammermann P. Rahmaoui C.M. Lee P.P. Sela-Herman S. Matula G.S. Ananthanarayanan M. Suchy F.J. Cavalieri R.R. Lomri N. Scharschmidt B.F. Gastroenterology. 1997; 113: 249-254Abstract Full Text PDF PubMed Scopus (15) Google Scholar). This assumption has recently been further supported by the cloning of an ATP-dependent bile salt transporter fromSaccharomyces cerevisiae (13Ortiz D.F. St. Pierre M.V. Abdulmassih A. Arias I.M. J. Biol. Chem. 1997; 272: 15358-15365Crossref PubMed Scopus (70) Google Scholar). This yeast bile salt transporter (BAT1) belongs to a subgroup of ABC-type proteins that includes also the canalicular multiorganic anion transporter or multidrug resistance protein MRP2 (human)/mrp2 (rat) (14Müller M. Jansen P.L.M. Am. J. Physiol. 1997; 272: G1285-G1303PubMed Google Scholar, 15Paulusma C.C. Bosma R.J. Zaman G.J.R. Bakker C.T.M. Otter M. Scheffer G.L. Scheper R.J. Borst P. Oude Elferink R.P.J. Science. 1996; 271: 1126-1128Crossref PubMed Scopus (804) Google Scholar, 16Büchler M. König J. Brom M. Kartenbeck J. Spring H. Horie T. Keppler D. J. Biol. Chem. 1996; 271: 15091-15098Abstract Full Text Full Text PDF PubMed Scopus (624) Google Scholar). Although MRP2/mrp2 mediates canalicular excretion of a broad range of divalent amphipathic anionic conjugates (1Oude Elferink R.P.J. Meijer D.K.F. Kuipers F. Jansen P.L.M. Groen A.K. Grotthuis G.M.M. Biochim. Biophys. Acta. 1995; 1241: 215-268Crossref PubMed Scopus (384) Google Scholar, 14Müller M. Jansen P.L.M. Am. J. Physiol. 1997; 272: G1285-G1303PubMed Google Scholar, 17Keppler D. König J. FASEB J. 1997; 11: 509-516Crossref PubMed Scopus (252) Google Scholar), it does not transport primary bile salts such as taurocholate or glycocholate (1Oude Elferink R.P.J. Meijer D.K.F. Kuipers F. Jansen P.L.M. Groen A.K. Grotthuis G.M.M. Biochim. Biophys. Acta. 1995; 1241: 215-268Crossref PubMed Scopus (384) Google Scholar, 18Madon J. Eckhardt U. Gerloff T. Stieger B. Meier P.J. FEBS Lett. 1997; 406: 75-78Crossref PubMed Scopus (91) Google Scholar). Therefore, we designed degenerate oligonucleotide primers spanning the Walker A and B motifs of ABC proteins and performed reverse transcription-polymerase chain reactin with total rat liver mRNA. One of the amplified fragments revealed an 88% identity with the published pig liver cDNA-fragment of the so called “sister of P-glycoprotein” (spgp), a novel putative canalicular ABC transporter of unknown function (19Childs S. Yeh R.L. Georges E. Ling V. Cancer Res. 1995; 55: 2029-2034PubMed Google Scholar). Here we report the full-length isolation of spgp from rat liver, demonstrate its function as an ATP-dependent bile salt transporter in cRNA-injectedXenopus laevis oocytes and in transfected Sf9 cells, and document its subcellular localization at the canalicular microvilli and at subcanalicular smooth membrane vesicles of rat hepatocytes using immunofluorescence and immunogold electron microscopy. [3H]Taurocholic acid (2.1–4.6 Ci/mmol), [3H]cholic acid (13.2 Ci/mmol), and [4C]glycocholic acid (44.6 mCi/mmol) were obtained from NEN Life Science Products. 3H-Labeled taurochenodeoxycholic and tauroursodeoxycholic acids of high specific activity (2–60 Ci/mmol) were prepared as described previously (20Kullak-Ublick G.A. Hagenbuch B. Stieger B Schteingart C.D. Hofmann A.F. Wolkoff A.W. Meier P.J. Gastroenterology. 1995; 109: 1274-1282Abstract Full Text PDF PubMed Scopus (373) Google Scholar, 21Duane W.C. Schteingart C.D. Ton-Nu H.T. Hofmann A.F. J. Lipid Res. 1996; 37: 431-436PubMed Google Scholar, 22Rossi S.S. Converse J.L. Hofmann A.F. J. Lipid Res. 1987; 28: 589-595Abstract Full Text PDF PubMed Google Scholar). All other chemicals and reagents were of analytical grade and were readily available from commercial sources. A cDNA probe spanning the Walker A and B motifs of ABC proteins was constructed by the reverse transcription-polymerase chain reaction of rat liver poly(A)+ RNA using the following primers: forward primers, GGCGGATCCTCIGGIKSIGGIAARAGYAC and GGCGGATCCTCIGGIKSIGGIAARTCIIC; reverse primers, CGGGAATTCTCIARIGCRCTIACIGSYTCRTC, CGGGAATTCTCIARIGCRCTIGTIGSYTCRTC, CGGGAATTCTCIARIGCICAIACIGSYTCRTC, and CGGGAATTCTCIARIGCIGAIGTIGSYTCRTC. After cloning and sequencing a single polymerase chain reaction product of 430 bp was identified that revealed an 88% identity to the published portion of the pig liver spgp cDNA (19Childs S. Yeh R.L. Georges E. Ling V. Cancer Res. 1995; 55: 2029-2034PubMed Google Scholar). It was used to sequentially isolate the full-length spgp cDNA from two cDNA libraries constructed from total rat liver mRNA with the Superscript Plasmid System (Life Technologies, Inc.) and from size-fractionated poly(A+) RNA (4.0–6.0 kb) using the ZAP ExpressTM cDNA Synthesis and ZAP ExpressTM cDNA Gigapack III Gold Cloning kits (Stratagene), respectively. The final single clone was sequenced by Microsynth Gmbh (Balgach, Switzerland). Oocytes were prepared, injected with cRNAs, cultured, and preloaded with 28.5 pmol of [3H]taurocholate (60 nl of 475 μm[3H]taurocholate (2.1 Ci/mmol)) as described elsewhere (23Hagenbuch B. Scharschmidt B.F. Meier P.J. Biochem J. 1996; 316: 901-904Crossref PubMed Scopus (112) Google Scholar, 24Shneider B.L. Moyer M.S. J. Biol. Chem. 1993; 268: 6985-6988Abstract Full Text PDF PubMed Google Scholar). [3H]Taurocholate efflux from individual oocytes was determined at 25 °C as described previously (18Madon J. Eckhardt U. Gerloff T. Stieger B. Meier P.J. FEBS Lett. 1997; 406: 75-78Crossref PubMed Scopus (91) Google Scholar, 24Shneider B.L. Moyer M.S. J. Biol. Chem. 1993; 268: 6985-6988Abstract Full Text PDF PubMed Google Scholar) using a Na+-free incubation medium of 100 mm choline chloride, 2 mm KCl, 1 mm CaCl2, 1 mm MgCl2, and 10 mm HEPES/Tris, pH 7.5. The Bac-to-Bac system (Life Technologies, Inc.) was used to generate the recombinant baculovirus. Sf9 cells were infected with virus and kept in culture (27 °C, air) for 72 h. Thereafter, Sf9 cells were scraped from culture dishes, centrifuged at 1400 × gav, and homogenized with a glass-Teflon tissue homogenizer in 50 mm mannitol, 2 mm EGTA, 50 mm Tris/HCl, pH 7.0, 1 μg/ml leupeptin/antipain, and 0.5 mm phenylmethylsulfonyl fluoride (25Sarkadi B. Price E.M. Boucher R.C. Germann U.A. Scarborough G.A. J. Biol. Chem. 1992; 267: 4854-4858Abstract Full Text PDF PubMed Google Scholar). Undisrupted cells, nuclear debris, and large mitochondria were pelleted at 500 × gavfor 10 min. The supernatant was centrifuged for 60 min at 100,000 × gav. The resulting pellet was resuspended in taurocholate uptake buffer consisting of 50 mm sucrose, 100 mm KNO3, 12.5 mmMg(NO3)2, and 10 mm HEPES/Tris, pH 7.4. The vesicles were stored frozen in liquid nitrogen. Protein was determined using the BCA assay with bovine serum albumin as a standard (26Smith P.K. Krohn R.I. Hermanson G.T. Mallia A.K. Gartner F.H. Provenzano M.D. Fujimoto E.K. Goeke N.M. Olson B.J. Klenk D.C. Anal. Biochem. 1985; 150: 76-85Crossref PubMed Scopus (18713) Google Scholar). A polyclonal antibody was raised in rabbits against an oligopeptide containing the C-terminal 13 amino acids coupled via cysteine to keyhole limpet hemocyanin (Neosystem, Strasbourg, France) and used for Western blotting as described previously (27Stieger B. Hagenbuch B. Landmann L. Höchli M. Schroeder A. Meier P.J. Gastroenterology. 1994; 107: 1781-1787Abstract Full Text PDF PubMed Google Scholar). A multiple tissue Northern blot (CLONTECH) (∼2 μg of poly(A+) RNA per lane) was hybridized with the full-length spgp cDNA clone or with a β-actin probe labeled with [α-32P]dCTP by random priming. Hybridization was performed at 65 °C overnight in Amersham hybridization buffer. The blot was washed at 68 °C in 0.2× SSC, 0.1% SDS. Immunofluorescence studies (27Stieger B. Hagenbuch B. Landmann L. Höchli M. Schroeder A. Meier P.J. Gastroenterology. 1994; 107: 1781-1787Abstract Full Text PDF PubMed Google Scholar) and immunogold electron microscopy studies on ultrathin frozen-thawed sections of perfusion-fixed (3% formaldehyde, 0.1% glutaraldehyde) liver were performed as described previously (28Tokuyasu K. Histochem. J. 1989; 21: 163-171Crossref PubMed Scopus (359) Google Scholar, 29Lackie P.M. Zuber C. Roth J. Development. 1990; 110: 933-947PubMed Google Scholar). The isolated full-length spgp cDNA 3The nucleotide sequence of the full-length spgp cDNA clone coding for the deduced amino acid sequence is deposited in the GenBankTM under accession number U69487. contained 5,036 base pairs and encoded a polypeptide of 1321 amino acids with 12 putative membrane-spanning domains, four predictedN-glycosylation sites in the first extracellular loop, and the typical structural features of ABC-transporting polypeptides (Fig. 1). Comparison of the full-length amino acid sequence with other members of the ABC-transporter superfamily revealed the following similarities/identities to spgp: mdr1a (mouse) 71%/50%, mdr1b (rat) 70%/49%, mdr2 (rat) 69%/48%, MRP1 (human) 51%/26%, mrp2 (rat) 49%/25%, BAT1 48%/23%, and cystic fibrosis conductance regulator (mouse) 48%/22%. These data confirm the close homology of spgp to the MDR/mdr gene family (19Childs S. Yeh R.L. Georges E. Ling V. Cancer Res. 1995; 55: 2029-2034PubMed Google Scholar). To elucidate its function, spgp was expressed in X. laevisoocytes (18Madon J. Eckhardt U. Gerloff T. Stieger B. Meier P.J. FEBS Lett. 1997; 406: 75-78Crossref PubMed Scopus (91) Google Scholar) and in Sf9 cells. As illustrated in Fig. 2, an approximately 1.5-fold increase in [3H]taurocholate efflux was observed in spgp cRNA-injected oocytes as compared with water- and mrp2 cRNA-injected oocytes (18Madon J. Eckhardt U. Gerloff T. Stieger B. Meier P.J. FEBS Lett. 1997; 406: 75-78Crossref PubMed Scopus (91) Google Scholar). In addition, membrane vesicles isolated from spgp cDNA-infected Sf9 cells (see “Experimental Procedures”) demonstrated marked ATP-dependent uptake of taurocholate, whereas control vesicles from wild type cells (or cells infected with wild type or with β-galactosidase-containing baculovirus; data not shown) did not (Fig. 3 A). Initial rates of this spgp-mediated, ATP-dependent [3H]taurocholate uptake exhibited saturability with increasing concentrations of taurocholate (Km value ∼5.3 μm) (Fig. 3 B). Furthermore, only minimal or no stimulation of [3H]taurocholate uptake into spgp expressing Sf9 vesicles was observed with other nucleotides (UTP, CTP, and GTP), ATP degradation products (ADP, AMP, and adenosine), or nonhydrolyzable ATP analogs (adenosine-5′-[γ-thio]triphosphate and adenosine-5′-[β,γ-imido]triphosphate) (data not shown). Also, increasing concentrations of vanadate between 5 μm and 100 μm inhibited ATP-dependent [3H]taurocholate uptake between 32% and 63%. And finally, comparison of initial ATP-dependent uptake rates (linear time-dependent uptake phase) of various bile salt derivatives in spgp-expressing Sf9 cell vesicles and in isolated canalicular liver plasma membrane vesicles (6Stieger B. O'Neill B. Meier P.J. Biochem. J. 1992; 284: 67-74Crossref PubMed Scopus (131) Google Scholar) showed the highest ATP-dependent uptake rate for taurochenodeoxycholate followed by tauroursodeoxycholate and taurocholate in both vesicle preparations (Table I). In contrast, glycocholate and cholate were less efficiently transported in canalicular vesicles, and no ATP-dependent transport of these bile salt derivatives could be detected in spgp-expressing Sf9 cell vesicles. These latter results most probably resulted from the overall lower expression of ATP-dependent bile salt transport activities in spgp-expressing Sf9 cells compared with canalicular vesicles (Table I), thus preventing the detection of low residual spgp-mediated cholate and glycocholate transport.Figure 3ATP-dependent taurocholate transport in membrane vesicles isolated from spgp-expressing Sf9 cells. A, effect of ATP on taurocholate uptake. Membrane vesicles isolated from wild type (control) and spgp-expressing Sf9 cells were incubated in 50 mm sucrose, 100 mm KNO3, 12.5 mmMg(NO3)2, and 10 mm HEPES/Tris, pH 7.4, supplemented with 2 μm[3H]taurocholate. Vesicle uptake of [3H]taurocholate was determined in the presence and absence of ATP (5 mm) (6Stieger B. O'Neill B. Meier P.J. Biochem. J. 1992; 284: 67-74Crossref PubMed Scopus (131) Google Scholar). ○, control vesicles without ATP; •, control vesicles with ATP; □, spgp-expressing vesicles without ATP, ▪, spgp-expressing vesicles with ATP. Data represent the means ± S.D. of three determinations with the variability being smaller than the symbols. B, saturability of spgp-mediated ATP-dependent taurocholate uptake. Initial uptakes of increasing taurocholate concentrations were determined at 30 s in the presence and absence of ATP (5 mm). ATP-dependent uptake values were determined by subtraction of uptake in the absence from uptake in the presence of ATP. The values are the means ± SD of triplicate determinations in one out of two separate experiments.View Large Image Figure ViewerDownload (PPT)Table IComparison of initial ATP-dependent bile salt transport in canalicular rat liver plasma membrane (cLPM) vesicles and in spgp-expressing SF9 cell vesiclesBile salt1-aAt 2 μm.cLPM vesiclesSf9 cell vesiclespmol/mg protein × minTaurochenodeoxycholate65 ± 930 ± 7Tauroursodeoxycholate48 ± 820 ± 2Taurocholate52 ± 423 ± 6Glycocholate9 ± 3ND1-bND, not detectable.Cholate6 ± 1ND1-a At 2 μm.1-b ND, not detectable. Open table in a new tab To directly correlate transport activity with protein expression in Sf9 cells, a polyclonal antiserum against the C-terminal 13 amino acids of BSEP/spgp was raised in rabbits. The antiserum recognized a predominant protein band with an apparent molecular mass of ∼140 kDa (140.5 ± 2.7; mean ± SD, n = 3) in vesicles isolated from BSEP/spgp cDNA-transfected Sf9 cells (Fig. 4 A, lane 2), but not in vesicles isolated from wild type cells (Fig. 4 A, lane 1) nor in vesicles isolated from Sf9 cells infected with wild type or with β-galactosidase containing baculovirus (data not shown). Thus, the expression of BSEP/spgp correlates with ATP-dependent taurocholate transport. An immunopositive protein band was also observed in canalicular, but not in basolateral plasma membrane vesicles isolated from rat liver (Fig. 4 A, lanes 3 and 4). This canalicular form of BSEP/spgp exhibited a slightly higher molecular mass of ∼160 kDa (157.4 ± 3.1; mean ± SD, n = 3), which most probably reflects a differentN-linked glycosylation pattern of hepatocytes as compared with Sf9 cells (25Sarkadi B. Price E.M. Boucher R.C. Germann U.A. Scarborough G.A. J. Biol. Chem. 1992; 267: 4854-4858Abstract Full Text PDF PubMed Google Scholar). Based on Northern blot analysis of various rat tissue mRNAs, BSEP/spgp is predominantly, if not exclusively, expressed in the liver (Fig. 4 B). When tested for its presence in other animal species the BSEP/spgp cDNA yielded positive hybridization reactions also with mRNAs of mouse (∼5.0 kb), chicken (∼2.0 kb), and turtle (∼4.0 kb) livers (data not shown), indicating the occurrence of BSEP/spgp-related proteins also in lower vertebrates. The cellular and subcellular distribution of BSEP/spgp in rat liver was further investigated by immunofluorescence and immunogold electron microscopy. At low magnification positive immunoreactivity was confined homogenously to bile canaliculi of periportal and perivenous hepatocytes (data not shown). No immunoreactivity was detected in bile ductular epithelial cells. Within bile canaliculi the immunoreactivity for BSEP/spgp was predominantly associated with the canalicular microvilli, while the smooth intermicrovillar plasma membrane regions were essentially free of gold particle labeling (Fig. 4, Cand D). No labeling was found along the basolateral plasma membrane of hepatocytes. Intracellularly, gold particle labeling was associated with subplasmalemmal smooth membrane vesicles, lucent vacuoles probably representing endosomes (Fig. 4, E and F) and the Golgi apparatus. This study has identified spgp (19Childs S. Yeh R.L. Georges E. Ling V. Cancer Res. 1995; 55: 2029-2034PubMed Google Scholar) as a canalicular ATP-dependent BSEP of mammalian liver. This conclusion is derived from the functional expression of the full-length BSEP/spgp cDNA in X. laevis oocytes (Fig. 2) and in Sf9 insect cells (Figs. 3 and 4 A). Vesicles isolated from BSEP/spgp-overexpressing Sf9 cells exhibited similar high affinity ATP-dependent taurocholate uptake (Km = ∼5.3 μm) (Fig. 3 B) as previously determined under identical conditions in canalicular rat liver plasma membrane vesicles (Km = ∼2.1 μm) (6Stieger B. O'Neill B. Meier P.J. Biochem. J. 1992; 284: 67-74Crossref PubMed Scopus (131) Google Scholar). Since canalicular secretion represents the rate-limiting step in the overall transport of bile salts from sinusoidal blood plasma into bile (2Nathanson M.H. Boyer J.L. Hepatology. 1991; 14: 551-566Crossref PubMed Scopus (385) Google Scholar, 8Meier P.J. Am. J. Physiol. 1995; 269: G801-G812PubMed Google Scholar), its high affinity for taurocholate indicates that BSEP/spgp represents the major canalicular bile salt transporter of rat liver. Based on Northern blot analysis, BSEP/spgp is predominantly, if not exclusively expressed in the liver (Fig. 4 B) (19Childs S. Yeh R.L. Georges E. Ling V. Cancer Res. 1995; 55: 2029-2034PubMed Google Scholar). This organ-selective expression of BSEP/spgp is not astonishing considering its bile salt transport function. However, BSEP/spgp-related proteins appear also to occur in the livers of other vertebrates including chicken and turtle (this study) as well as the winter flounder (34Chan K.M.C. Davies P.L. Childs S. Veinot L. Ling V. Biochim. Biophys. Acta. 1992; 1171: 65-72Crossref PubMed Scopus (54) Google Scholar), supporting the concept that the origin of the BSEP/spgp gene predates the divergence of fish and mammals (19Childs S. Yeh R.L. Georges E. Ling V. Cancer Res. 1995; 55: 2029-2034PubMed Google Scholar) and that BSEP/spgp mediates the transport of C27 bile acids (present in turtle) as well as C24 bile acids (present in most mammals and chickens). Finally, Western blot analysis as well as immunofluorescence and immunogold labeling studies demonstrated the selective localization of BSEP/spgp at the canalicular microvilli (Fig. 4, A,C, and D) and at subcanalicular smooth membrane vesicles (Fig. 4, E and F) of rat hepatocytes. Since infusion of taurocholate into intact animals has been shown to increase the canalicular bile salt transport capacity (2Nathanson M.H. Boyer J.L. Hepatology. 1991; 14: 551-566Crossref PubMed Scopus (385) Google Scholar, 35Gatmaitan Z.C. Nies A.T. Arias I.M. Am. J. Physiol. 1997; 272: G1041-G1049PubMed Google Scholar), the labeled subcanalicular endosomes might represent a regulatory carrier pool that could be rapidly inserted into the canalicular plasma membrane under high bile salt load conditions. The full length of the rat liver BSEP/spgp represents a canalicular protein with a molecular mass of ∼160 kDa (Fig. 4 A). Its homology to the MDR/mdr gene family is in contrast to the closer relatedness of the recently cloned yeast BAT1 with the MRP/mrp gene family of ABC transporters (13Ortiz D.F. St. Pierre M.V. Abdulmassih A. Arias I.M. J. Biol. Chem. 1997; 272: 15358-15365Crossref PubMed Scopus (70) Google Scholar). Since mammalian MRP/mrp analogues do not mediate transport of monovalent bile salt derivatives (1Oude Elferink R.P.J. Meijer D.K.F. Kuipers F. Jansen P.L.M. Groen A.K. Grotthuis G.M.M. Biochim. Biophys. Acta. 1995; 1241: 215-268Crossref PubMed Scopus (384) Google Scholar, 4Müller M. Ishikawa T. Berger U. Klünemann C. Lucka L. Schreyer A. Kannicht C. Reutter W. Kurz G. Keppler G. J. Biol. Chem. 1991; 266: 18920-18926Abstract Full Text PDF PubMed Google Scholar, 17Keppler D. König J. FASEB J. 1997; 11: 509-516Crossref PubMed Scopus (252) Google Scholar, 18Madon J. Eckhardt U. Gerloff T. Stieger B. Meier P.J. FEBS Lett. 1997; 406: 75-78Crossref PubMed Scopus (91) Google Scholar), and since BAT1 has been shown to exhibit an approximately 12-fold lower affinity for taurocholate (Km = ∼63 μm) (13Ortiz D.F. St. Pierre M.V. Abdulmassih A. Arias I.M. J. Biol. Chem. 1997; 272: 15358-15365Crossref PubMed Scopus (70) Google Scholar) as compared with BSEP/spgp (Fig. 3 B), the participation ofBAT1-related gene products in bile salt transport in mammalian liver seems unlikely. Furthermore, since fungi are thought to be devoid of bile salts, the true endogenous substrate(s) of BAT1 as well as the functional significance of bile salt transport in yeast remain unclear. Nevertheless, ATP-dependent taurocholate transport has also been demonstrated in plant vacuoles despite the absence of typical bile salts in plant tissue (36Hortensteiner S. Vogt E. Hagenbuch B Meier P.J. Amrhein N. Martinoia E. J. Biol. Chem. 1993; 268: 18446-18449Abstract Full Text PDF PubMed Google Scholar). Hence, amphipathic bile salt transport might be a nonspecific “bystander” function of several multispecific ABC-type transporters in a variety of biological tissues. In contrast, ongoing bile salt secretion serves an essential function in mammalian liver, where it mediates phospholipid and cholesterol excretion and water flow into bile canaliculi. Furthermore, in vertebrates bile salts are 100–1000-fold concentrated in bile as compared with plasma, stimulate absorption of lipids from the intestine and undergo efficient enterohepatic circulation (2Nathanson M.H. Boyer J.L. Hepatology. 1991; 14: 551-566Crossref PubMed Scopus (385) Google Scholar, 8Meier P.J. Am. J. Physiol. 1995; 269: G801-G812PubMed Google Scholar, 9Suchy F.J. Sippel C.J. Ananthanarayanan M. FASEB J. 1997; 11: 199-205Crossref PubMed Scopus (52) Google Scholar). Therefore, it is conceivable that vertebrates have developed a separate high affinity bile salt export pump within the large superfamily of ABC-type proteins. Several observations from this and other recent studies strongly indicate that BSEP/spgp represents the major, if not the only bile salt export pump in mammalian liver. First, BSEP/spgp-mediated bile salt transport exhibits similar kinetics (see above) and similar substrate preference (Table I) as ATP-dependent bile salt transport in canalicular liver plasma membrane vesicles (6Stieger B. O'Neill B. Meier P.J. Biochem. J. 1992; 284: 67-74Crossref PubMed Scopus (131) Google Scholar). Second, preferential BSEP/spgp-mediated transport of the dihydroxy-conjugated bile salt taurochenodeoxycholate is consistent with the preferential secretion and transport of this bile salt in the isolated perfused liver and in canalicular plasma membrane vesicles (37Bolder U. Ton-Nu H.T. Schteingart C.D. Frick E. Hofmann A.F. Gastroenterology. 1997; 112: 214-225Abstract Full Text PDF PubMed Scopus (204) Google Scholar). Third, in contrast to the ecto-ATPase canalicular expression of BSEP/spgp is decreased in various forms of cholestatic liver disease (38Müller M. Vos T.A. Roelofsen H. van Goor H. Moshage H. Kuipers F. Jansen P.L.M. J. Hepatol. 1997; 26 (abstr.): 71Crossref Scopus (240) Google Scholar, 39Green R.M. Beier D. Gollan J.L. Gastroenterology. 1996; 111: 193-198Abstract Full Text Full Text PDF PubMed Scopus (260) Google Scholar, 40Trauner M. Arrese M. Lee H.R. Soroka C. Ananthanarayanan M. Koeppel T.A. Schlosser S.F. Boyer J.L. Gastroenterology. 1997; 113: 255-264Abstract Full Text PDF PubMed Scopus (462) Google Scholar), and its level of expression correlates well with the activity of ATP-dependent canalicular bile salt transport (37Bolder U. Ton-Nu H.T. Schteingart C.D. Frick E. Hofmann A.F. Gastroenterology. 1997; 112: 214-225Abstract Full Text PDF PubMed Scopus (204) Google Scholar, 38Müller M. Vos T.A. Roelofsen H. van Goor H. Moshage H. Kuipers F. Jansen P.L.M. J. Hepatol. 1997; 26 (abstr.): 71Crossref Scopus (240) Google Scholar). Fourth, overexpression of BSEP/spgp is associated with increased bile salt secretion in a gallstone susceptible mouse strain (41Lammert F. Beier D.R. Wang D.O.H. Carey M.C. Paigen B. Cohen D.E. Hepatology. 1997; 26: 358ACrossref PubMed Scopus (0) Google Scholar). And fifth, the BSEP/spgp gene is localized on the same chromosome (chromosome 2) as the locus for progressive familial intrahepatic cholestasis PFIC2 (41Lammert F. Beier D.R. Wang D.O.H. Carey M.C. Paigen B. Cohen D.E. Hepatology. 1997; 26: 358ACrossref PubMed Scopus (0) Google Scholar, 42Thompson R.J. Strautnieks S.S. Kagalwalla A.F. Tanner M.S. Knisely A.S. Bull L.N. Freimer N.B. Kocoshis S.A. Dahl N. Arnell H. Sokal E. Gardiner R.M. Hepatology. 1997; 26: 383AGoogle Scholar, 43Strautnieks S.S. Kagalwalla A.F. Tanner M.S. Knisely A.S. Bull L. Freimer N. Kocoshis S.A. Gardiner R.M. Thompson R.J. Am. J. Hum. Genet. 1997; 61: 630-633Abstract Full Text PDF PubMed Scopus (175) Google Scholar), which is characterized by defective canalicular bile salt secretion in the presence of normal serum cholesterol and normal plasma γ-glutamyltranspeptidase (44Whitington P.F. Freese D.K. Alonso E.M. Schwarzenberg S.J. Sharp H.L. J. Pediatr. Gastroenterol. Nutr. 1994; 18: 134-141Crossref PubMed Scopus (243) Google Scholar). These patients secrete exceptionally low levels of conjugated primary bile salts into bile and have particularly low levels of biliary chenodeoxycholic acid (45Jacquemin E. Dumont M. Bernard O. Erlinger S. Hadchouel M. Eur. J. Pediatr. 1994; 153: 424-428Crossref PubMed Scopus (89) Google Scholar, 46Tazawa Y. Yamada M. Nakagawa M. Konno T. Tada K. J. Pediatr. Gastroent. Nutr. 1985; 4: 32-37Crossref PubMed Scopus (39) Google Scholar), which represents the preferred substrate of BSEP/spgp (Table I). In fact, and most importantly, in preliminary studies missense mutations of the human liver SPGPgene have been identified as the most probable cause of PFIC linked to the PFIC2 locus (42Thompson R.J. Strautnieks S.S. Kagalwalla A.F. Tanner M.S. Knisely A.S. Bull L.N. Freimer N.B. Kocoshis S.A. Dahl N. Arnell H. Sokal E. Gardiner R.M. Hepatology. 1997; 26: 383AGoogle Scholar). 4R. J. Thompson, personal communication. These very recent developments corroborate the findings presented in this study and further support the conclusion that BSEP/spgp represents the major, if not the only canalicular bile salt transporter of mammalian liver." @default.
• W2061569374 created "2016-06-24" @default.
• W2061569374 creator A5008264088 @default.
• W2061569374 creator A5012206077 @default.
• W2061569374 creator A5042283235 @default.
• W2061569374 creator A5062829076 @default.
• W2061569374 creator A5073680043 @default.
• W2061569374 creator A5084194547 @default.
• W2061569374 creator A5090844389 @default.
• W2061569374 creator A5091424046 @default.
• W2061569374 date "1998-04-01" @default.
• W2061569374 modified "2023-10-11" @default.
• W2061569374 title "The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver" @default.
• W2061569374 cites W1480668470 @default.
• W2061569374 cites W1481602754 @default.
• W2061569374 cites W1544908228 @default.
• W2061569374 cites W1562429746 @default.
• W2061569374 cites W1564537703 @default.
• W2061569374 cites W1574436763 @default.
• W2061569374 cites W1802502124 @default.
• W2061569374 cites W1928009957 @default.
• W2061569374 cites W1966310113 @default.
• W2061569374 cites W1969339813 @default.
• W2061569374 cites W1974338599 @default.
• W2061569374 cites W1974585233 @default.
• W2061569374 cites W1974599572 @default.
• W2061569374 cites W1975304761 @default.
• W2061569374 cites W1978412289 @default.
• W2061569374 cites W1987859281 @default.
• W2061569374 cites W1989306680 @default.
• W2061569374 cites W1996147548 @default.
• W2061569374 cites W1997902724 @default.
• W2061569374 cites W1998275215 @default.
• W2061569374 cites W2012386903 @default.
• W2061569374 cites W2012676911 @default.
• W2061569374 cites W2020673576 @default.
• W2061569374 cites W2026582002 @default.
• W2061569374 cites W2030438923 @default.
• W2061569374 cites W2031580730 @default.
• W2061569374 cites W2033265977 @default.
• W2061569374 cites W2045875385 @default.
• W2061569374 cites W2055630306 @default.
• W2061569374 cites W2068233575 @default.
• W2061569374 cites W2073798993 @default.
• W2061569374 cites W2082168419 @default.
• W2061569374 cites W2120825516 @default.
• W2061569374 cites W2152438501 @default.
• W2061569374 cites W2154283357 @default.
• W2061569374 cites W2160746350 @default.
• W2061569374 cites W2170734806 @default.
• W2061569374 cites W2305211248 @default.
• W2061569374 cites W2324057214 @default.
• W2061569374 cites W2345690295 @default.
• W2061569374 cites W4232534952 @default.
• W2061569374 cites W73989749 @default.
• W2061569374 doi "https://doi.org/10.1074/jbc.273.16.10046" @default.
• W2061569374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9545351" @default.
• W2061569374 hasPublicationYear "1998" @default.
• W2061569374 type Work @default.
• W2061569374 sameAs 2061569374 @default.
• W2061569374 citedByCount "879" @default.
• W2061569374 countsByYear W20615693742012 @default.
• W2061569374 countsByYear W20615693742013 @default.
• W2061569374 countsByYear W20615693742014 @default.
• W2061569374 countsByYear W20615693742015 @default.
• W2061569374 countsByYear W20615693742016 @default.
• W2061569374 countsByYear W20615693742017 @default.
• W2061569374 countsByYear W20615693742018 @default.
• W2061569374 countsByYear W20615693742019 @default.
• W2061569374 countsByYear W20615693742020 @default.
• W2061569374 countsByYear W20615693742021 @default.
• W2061569374 countsByYear W20615693742022 @default.
• W2061569374 countsByYear W20615693742023 @default.
• W2061569374 crossrefType "journal-article" @default.
• W2061569374 hasAuthorship W2061569374A5008264088 @default.
• W2061569374 hasAuthorship W2061569374A5012206077 @default.
• W2061569374 hasAuthorship W2061569374A5042283235 @default.
• W2061569374 hasAuthorship W2061569374A5062829076 @default.
• W2061569374 hasAuthorship W2061569374A5073680043 @default.
• W2061569374 hasAuthorship W2061569374A5084194547 @default.
• W2061569374 hasAuthorship W2061569374A5090844389 @default.
• W2061569374 hasAuthorship W2061569374A5091424046 @default.
• W2061569374 hasBestOaLocation W20615693741 @default.
• W2061569374 hasConcept C104317684 @default.
• W2061569374 hasConcept C108625454 @default.
• W2061569374 hasConcept C147789679 @default.
• W2061569374 hasConcept C149011108 @default.
• W2061569374 hasConcept C185592680 @default.
• W2061569374 hasConcept C2776371256 @default.
• W2061569374 hasConcept C2910800957 @default.
• W2061569374 hasConcept C55493867 @default.
• W2061569374 hasConceptScore W2061569374C104317684 @default.
• W2061569374 hasConceptScore W2061569374C108625454 @default.
• W2061569374 hasConceptScore W2061569374C147789679 @default.
• W2061569374 hasConceptScore W2061569374C149011108 @default.
• W2061569374 hasConceptScore W2061569374C185592680 @default.
• W2061569374 hasConceptScore W2061569374C2776371256 @default.
• W2061569374 hasConceptScore W2061569374C2910800957 @default.

• next